Sort
326,823 grants matching “clinical trial”
Action for Health in Diabetes (Look AHEAD)
$1,595,718David M Nathan · Massachusetts General Hospital · U01 · FY2012 · DK
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
$1,595,693John V Frangioni · Curadel, Llc · R44 · FY2021 · CA
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
$1,595,693John V Frangioni · Curadel, Llc · R44 · FY2020 · CA
Alliance for Clinical Trials in Oncology Operations Center
$1,595,651Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2016 · CA
Core--Vector
$1,595,516Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2007 · AI
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,595,511Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2021 · AG
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
$1,595,317Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2018 · CA
Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNTâ (ASCENT) Clinical Trial
$1,595,294Andrea Lynne Cheville · Mayo Clinic Rochester · R33 · FY2025 · CA
COLORADO ADULT AIDS CLINICAL TRIALS UNIT
$1,595,271Thomas B. Campbell · University Of Colorado Denver · U01 · FY2006 · AI
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$1,595,216Richard C. Mohs · Agenebio, Inc. · R01 · FY2022 · AG
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV prevention Behaviors in Diverse Adolescent MSM
$1,595,193Rebecca Schnall · Columbia University Health Sciences · U01 · FY2016 · MD
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial
$1,594,969Edwin D Boudreaux · Univ Of Massachusetts Med Sch Worcester · U01 · FY2013 · MH
Novel Small Molecule Inhibitors of Botulinum Neurotoxin A
$1,594,896Terry L Bowlin · Microbiotix, Inc · U01 · FY2007 · AI
Trial to Assess Chelation Therapy 2 (TACT2) DCC
$1,594,889Kevin J Anstrom · Duke University · UH3 · FY2019 · AT
Modification of hyperthermia response
$1,594,884Thomas Jefferson University · P01 · FY2005 · CA
Transition to Human Phase 1b Trials: Nonclinical Studies of an Anti-METH mAb
$1,594,873Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2015 · DA
ICH Removal: Minimally Invasive Surgery + rt-PA
$1,594,839Daniel F Hanley · Johns Hopkins University · R01 · FY2010 · NS
Coalition for harm reduction and prevention (CHRP): Developing and testing a novel Hub and Spoke Model to implement prevention and harm reduction in rural clinics
$1,594,805Lewei Allison Lin · University Of Michigan At Ann Arbor · R61 · FY2024 · DA
Implementation science to scale and sustain tobacco treatment leveraging point of care paradigm and health information technology
$1,594,797Li-Shiun Chen · Washington University · UG3 · FY2025 · CA
Anatomic Pathology Residency Program
$1,594,760John Oberholtzer · Division Of Basic Sciences - Nci · ZIE · FY2011 · CA
Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNTâ (ASCENT) Clinical Trial
$1,594,666Andrea Lynne Cheville · Mayo Clinic Rochester · R33 · FY2024 · CA
Long-term, non-clinical toxicology for advancing CMS121 to Phase 2 trials for AD
$1,594,649William C Raschke · Virogenics, Inc. · U01 · FY2024 · AG
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER
$1,594,634Henry Ford Health System · N01 · FY2000 · CN
Preclinical Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,594,607Philip Lograsso · Scripps Research Institute, The · U01 · FY2012 · NS
Preclinial Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,594,607Philip Lograsso · Scripps Research Institute, The · U01 · FY2012 · NS